ATE246935T1 - Zns neuroregenerative zusammensetzungen und deren verwendungen - Google Patents

Zns neuroregenerative zusammensetzungen und deren verwendungen

Info

Publication number
ATE246935T1
ATE246935T1 AT98926325T AT98926325T ATE246935T1 AT E246935 T1 ATE246935 T1 AT E246935T1 AT 98926325 T AT98926325 T AT 98926325T AT 98926325 T AT98926325 T AT 98926325T AT E246935 T1 ATE246935 T1 AT E246935T1
Authority
AT
Austria
Prior art keywords
cns
neural growth
neuroregenerative
compositions
neuroregenerative compositions
Prior art date
Application number
AT98926325T
Other languages
English (en)
Inventor
Ann Logan
Martin Berry
Original Assignee
Acorda Therapeutics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acorda Therapeutics filed Critical Acorda Therapeutics
Application granted granted Critical
Publication of ATE246935T1 publication Critical patent/ATE246935T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Environmental Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT98926325T 1997-06-11 1998-06-10 Zns neuroregenerative zusammensetzungen und deren verwendungen ATE246935T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87326797A 1997-06-11 1997-06-11
PCT/US1998/011619 WO1998056404A1 (en) 1997-06-11 1998-06-10 Cns neuroregenerative compositions and methods of use

Publications (1)

Publication Number Publication Date
ATE246935T1 true ATE246935T1 (de) 2003-08-15

Family

ID=25361299

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98926325T ATE246935T1 (de) 1997-06-11 1998-06-10 Zns neuroregenerative zusammensetzungen und deren verwendungen

Country Status (8)

Country Link
EP (1) EP0989859B1 (de)
JP (1) JP2002512627A (de)
AT (1) ATE246935T1 (de)
AU (1) AU749530B2 (de)
CA (1) CA2293492A1 (de)
DE (1) DE69817180D1 (de)
WO (1) WO1998056404A1 (de)
ZA (1) ZA985090B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6815431B2 (en) 1998-04-15 2004-11-09 Regents Of The University Of California Methods for therapy of neurodegenerative disease of the brain
US6683058B1 (en) 1998-04-15 2004-01-27 Regents Of The University Of California Methods for therapy of neurodegenerative disease of the brain
WO2000028324A1 (en) * 1998-11-10 2000-05-18 Mcgill University Methods for identifying modulators of neuronal growth
IL153831A0 (en) * 2000-07-19 2003-07-31 Univ California Methods for therapy of neurodegenerative disease of the brain
US20090082263A1 (en) * 2004-07-29 2009-03-26 Anges, Mg, Inc. Drug and method for improving brain function
US20100215722A1 (en) * 2006-02-28 2010-08-26 Vishal Bhasin Tissue Regeneration II
EP2095826B1 (de) * 2006-11-17 2012-12-26 The Research Foundation for Microbial Diseases of Osaka University Nervenelongationspromoter und elongationshemmer
CN101980668A (zh) * 2008-02-07 2011-02-23 赛拉基因公司 通过玻璃体内施用编码治疗用蛋白质的表达载体救援光感器
MX369925B (es) * 2013-07-05 2019-11-25 Arla Foods Amba Osteopontina lactea de mamifero para mejorar la capacidad de respuesta inmunitaria.
RU2732479C2 (ru) * 2018-12-21 2020-09-17 Селл энд Джин Терапи Лтд Генотерапевтический ДНК-вектор на основе генотерапевтического ДНК-вектора VTvaf17, несущий целевой ген, выбранный из группы генов BDNF, VEGFA, BFGF, NGF, GDNF, NT3, CNTF, IGF1, для повышения уровня экспрессии этих целевых генов, способ его получения и применения, штамм Escherichia coli SCS110-AF/VTvaf17-BDNF, или Escherichia coli SCS110-AF/VTvaf17-VEGFA, или Escherichia coli SCS110-AF/VTvaf17-BFGF, или Escherichia coli SCS110-AF/VTvaf17-NGF, или Escherichia coli SCS110-AF/VTvaf17-GDNF, или Escherichia coli SCS110-AF/VTvaf17-NT3, или Escherichia coli SCS110-AF/VTvaf17-CNTF, или Escherichia coli SCS110-AF/VTvaf17-IGF1, несущий генотерапевтический ДНК-вектор, способ его получения, способ производства в промышленных масштабах генотерапевтического ДНК-вектора
CN112138143B (zh) * 2019-06-26 2024-08-23 杭州生物医药创新研究中心 一种用于治疗神经损伤疾病的药物组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5082670A (en) * 1988-12-15 1992-01-21 The Regents Of The University Of California Method of grafting genetically modified cells to treat defects, disease or damage or the central nervous system
JPH0418031A (ja) * 1989-02-16 1992-01-22 Hiroshi Saito 損傷治癒促進剤
WO1993008828A1 (en) * 1991-11-08 1993-05-13 Syntex-Synergen Neuroscience Joint Venture Methods for the treatment of neuronal damage associated with ischemia, hypoxia or neurodegeneration
AU4995193A (en) * 1992-08-04 1994-03-03 Regeneron Pharmaceuticals, Inc. Method of enhancing differentiation and survival of neuronal precursor cells
ES2061380B1 (es) * 1992-11-23 1995-07-01 Boehringer Ingelheim Espana Empleo del factor de crecimiento fibroblastico y sus derivados como neuroprotectores y neuromoduladores.
US5602309A (en) * 1993-10-04 1997-02-11 University Of Kentucky Research Foundation Transgenic mice which overexpress nerve growth factor

Also Published As

Publication number Publication date
AU749530B2 (en) 2002-06-27
WO1998056404A1 (en) 1998-12-17
EP0989859B1 (de) 2003-08-13
ZA985090B (en) 1999-03-29
AU7818798A (en) 1998-12-30
CA2293492A1 (en) 1998-12-17
JP2002512627A (ja) 2002-04-23
EP0989859A1 (de) 2000-04-05
DE69817180D1 (de) 2003-09-18

Similar Documents

Publication Publication Date Title
EP0653940A4 (de) Glialmitogene faktoren, ihre herstellung und verwendung.
ATE404583T1 (de) Funktionelle antagonisten von hedgehog-aktivität
GR3034094T3 (en) Viral recombinant vectors for expression in muscle cells.
DE69435096D1 (de) Zusammensetzung zur in vivo erzeugung von therapeutischen produkten
WO1999046366A8 (en) Uses for humane non-autologous mesenchymal stem cells
IL148060A0 (en) Compositions and methods for improved cell culture
ATE117375T1 (de) Transduktionsveränderte fibroblasten und ihre anwendung.
AU9096001A (en) G-csf analog compositions and methods
NZ223549A (en) Macromolecular antitumour compositions containing platinum
ES2143478T3 (es) Sintesis de procolagenos y colagenos humanos en sistemas de adn de recombinacion.
ATE246935T1 (de) Zns neuroregenerative zusammensetzungen und deren verwendungen
DE69726884D1 (de) Menschliches sdf-5 protein und diesbezügliche zusammensetzungen
DK0920448T3 (da) Trunkeret gliacellelinie-afledt neurotrof faktor
WO1997026322A3 (en) Methods and compositions for inhibiting hexokinase
PL325646A1 (en) Transplantation of nerve cells using pluripotential nuroepithelial cells
ATE290789T1 (de) Verwendungsmethoden von einkernigen phagozyten zur förderung der axonalen regeneration
DK0904282T3 (da) Hidtil ukendte kationiske cholesterylderivater indeholdende cykliske polære grupper
PT1007559E (pt) Celulas geneticamente modificadas que expressam as proteinas morfogeneticas do osso
IL126221A0 (en) Scf analog compositions and methods
GB2322132B (en) Keratinocyte growth factor-2 products
TR200000532T2 (tr) Salgılanan proteinleri kodlayan genler kullanılan terapiler için yöntemler ve bileşimler.
DE69529750D1 (de) Verbesserungen in der herstellung von proteinen in wirtszellen
DE69939825D1 (de) Genetische transduktion von hämatopoietische vorläuferzellen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties